About Immunome Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://immunome.com/
Frequently Asked Questions
What is the 52-week range for IMNM?
The 52-week high is $30.06 and the 52-week low is $11.25.
What is the P/E ratio for IMNM?
The P/E ratio data is currently unavailable.
What is the dividend yield for IMNM?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -50.56%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -1687.08%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.74.
Analyst Recommendation Trends
Wall Street analyst consensus for IMNM over the last few months:
Latest IMNM News
Immunome (IMNM) Is Down 6.5% After FDA Clears IND For Novel ADC IM-1340 Trial – Has The Bull Case Changed?
Immunome, Inc. recently reported that the FDA cleared its Investigational New Drug application for IM-1340, a potential first-in-class antibody-drug conjugate for advanced solid tumors, enabling the company to begin a Phase 1 trial focused on safety, tolerability, pharmacokinetics, and early anti-tumor activity. By pairing a transport receptor broadly expressed across solid tumors with its proprietary HC74 topoisomerase I inhibitor payload, Immunome is adding another differentiated oncology...
Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues
Immunome has delivered a powerful multi year share price run, and the question now is whether the current US$21.51 price lines up with the cash flows that can support it. With the spotlight on its pipeline progress, the valuation story increasingly comes back to what the company’s future cash generation may justify. Immunome’s share price has gained 186.4% over the past 3 years, which puts a lot of weight on whether its cash flows can eventually back up that kind of move. The recent FDA...
Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24
Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.
Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors
BOTHELL, Wash., September 30, 2026--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for IM-1340, a potential first-in-class antibody-drug conjugate (ADC) for the treatment of advanced solid tumors.
Immunome Receives FDA Clearance For Its Investigational New Drug Application For IM-1340 To Treat Advanced Solid Tumors
Immunome, Inc. (NASDAQ:IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the U.S. Food and Drug Administration
Alliance Global Partners Initiates Coverage On Immunome with Buy Rating, Announces Price Target of $32
Alliance Global Partners analyst Matthew Venezia initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target of $32.
HC Wainwright & Co. Reiterates Buy on Immunome, Maintains $40 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Immunome (NASDAQ:IMNM) with a Buy and maintains $40 price target.
ServiceTitan, Braze, Target Hospitality And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. futures were mixed; ServiceTitan plunged 16.7% on weak Q3 guidance, while Mind Technology, Braze and others also fell premarket.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-11 | Higgins Jack | +18,000 | - | - |
| 2026-09-11 | Higgins Jack | -8,800 | - | - |
| 2026-09-11 | Higgins Jack | -13,200 | $25.32 | $334,224 |
| 2026-09-11 | Higgins Jack | +18,000 | $1.35 | $24,300 |
| 2026-08-12 | Barchas Isaac | -11,048 | $27.25 | $301,058 |
| 2026-08-11 | Barchas Isaac | -62,291 | $26.23 | $1,633,893 |
| 2026-08-10 | Barchas Isaac | -10,125 | $26.07 | $263,959 |
| 2026-08-07 | Barchas Isaac | -15,248 | $26.06 | $397,363 |
| 2026-08-06 | Barchas Isaac | -20,840 | $26.06 | $543,090 |
| 2026-08-04 | Horn Kinney | -40,250 | - | - |
| 2026-08-04 | Horn Kinney | -50,366 | - | - |
| 2026-08-04 | Horn Kinney | -90,616 | $25.09 | $2,273,555 |
| 2026-08-04 | Horn Kinney | +40,250 | $10.6 | $426,650 |
| 2026-08-04 | Horn Kinney | +50,366 | $12.92 | $650,729 |
| 2026-07-23 | Tsai Philip | +76,500 | - | - |
| 2026-07-23 | Tsai Philip | +38,250 | - | - |
| 2026-07-23 | Lechleider Robert | +108,000 | - | - |
| 2026-07-23 | Lechleider Robert | +54,000 | - | - |
| 2026-07-23 | Rosett Max | +94,500 | - | - |
| 2026-07-23 | Rosett Max | +47,250 | - | - |
| 2026-07-23 | Higgins Jack | +76,500 | - | - |
| 2026-07-23 | Higgins Jack | +38,250 | - | - |
| 2026-07-23 | Horn Kinney | +62,500 | - | - |
| 2026-07-23 | Horn Kinney | +31,250 | - | - |
| 2026-07-23 | Stoneman Sandra G. | +76,500 | - | - |
| 2026-07-23 | Stoneman Sandra G. | +38,250 | - | - |
| 2026-07-23 | SIEGALL CLAY B | +360,000 | - | - |
| 2026-07-23 | SIEGALL CLAY B | +180,000 | - | - |
| 2026-07-07 | Horn Kinney | -1,092 | - | - |
| 2026-07-07 | Horn Kinney | -1,092 | $25 | $27,300 |
| 2026-07-07 | Horn Kinney | +1,092 | $12.92 | $14,109 |
| 2026-07-07 | Barchas Isaac | -16,906 | $24.2 | $409,125 |
| 2026-07-06 | Barchas Isaac | -83,094 | $24.11 | $2,003,396 |
| 2026-07-02 | Lechleider Robert | -55,000 | - | - |
| 2026-07-02 | Lechleider Robert | -16,072 | $23.44 | $376,728 |
| 2026-07-02 | Lechleider Robert | -16,214 | $22.76 | $369,031 |
| 2026-07-02 | Lechleider Robert | -22,714 | $21.95 | $498,572 |
| 2026-07-02 | Lechleider Robert | +55,000 | $8.73 | $480,150 |
| 2026-07-02 | Barchas Isaac | -24,335 | $23.33 | $567,736 |
| 2026-07-02 | Barchas Isaac | -75,665 | $22.35 | $1,691,113 |
| 2026-06-30 | Barchas Isaac | -101,050 | $21.12 | $2,134,176 |
| 2026-06-15 | Rosett Max | -60,000 | - | - |
| 2026-06-15 | Rosett Max | -60,000 | $18.23 | $1,093,800 |
| 2026-06-15 | Rosett Max | +60,000 | $1.05 | $63,000 |
| 2026-06-10 | Boylan James P | +9,897 | - | - |
| 2026-06-10 | SWAIN SANDRA M | +9,897 | - | - |
| 2026-06-10 | Barchas Isaac | +9,897 | - | - |
| 2026-06-10 | WAGENHEIM PHILIP | +9,897 | - | - |
| 2026-06-10 | SCHAFER CAROL | +9,897 | - | - |
| 2026-06-10 | BIENAIME JEAN JACQUES | +9,897 | - | - |
| 2026-06-05 | BIENAIME JEAN JACQUES | +1,000 | $19.27 | $19,270 |
| 2026-06-05 | BIENAIME JEAN JACQUES | +3,500 | $19.46 | $68,110 |
| 2026-06-05 | BIENAIME JEAN JACQUES | +6,000 | $19.48 | $116,880 |
| 2026-06-05 | BIENAIME JEAN JACQUES | -10,000 | $19.41 | $194,100 |
| 2026-06-05 | BIENAIME JEAN JACQUES | -500 | $19.44 | $9,720 |
| 2026-05-15 | BIENAIME JEAN JACQUES | +5,000 | $20.7 | $103,500 |
| 2026-04-02 | Rosett Max | -39,713 | - | - |
| 2026-04-02 | Rosett Max | -31,848 | - | - |
| 2026-04-02 | Rosett Max | -1,344 | $22.48 | $30,213 |
| 2026-04-02 | Rosett Max | -63,656 | $21.91 | $1,394,703 |
| 2026-04-02 | Rosett Max | +39,713 | $1.35 | $53,613 |
| 2026-04-02 | Rosett Max | +31,848 | $1.05 | $33,440 |
| 2026-04-02 | Higgins Jack | -9,438 | $21.64 | $204,238 |
| 2026-03-30 | Higgins Jack | -6,291 | - | - |
| 2026-03-27 | SIEGALL CLAY B | +25,450 | $19.67 | $500,602 |
| 2026-03-23 | WAGENHEIM PHILIP | -28,200 | $20.65 | $582,330 |
| 2026-03-20 | WAGENHEIM PHILIP | -36,800 | $20.47 | $753,296 |
| 2026-03-11 | BIENAIME JEAN JACQUES | +1,000 | $21.55 | $21,550 |
| 2026-03-10 | BIENAIME JEAN JACQUES | +1,000 | $22.12 | $22,120 |
| 2025-12-30 | SIEGALL CLAY B | +4,729 | $21.15 | $100,018 |
| 2025-12-22 | Barchas Isaac | -11,251 | $22.34 | $251,347 |
| 2025-12-22 | Barchas Isaac | -371,949 | $21.72 | $8,078,732 |
| 2025-12-19 | Tsai Philip | +10,000 | $20.49 | $204,900 |
| 2025-12-19 | Higgins Jack | +1,000 | - | - |
| 2025-12-19 | Higgins Jack | -1,000 | - | - |
| 2025-12-19 | Higgins Jack | +1,000 | - | - |
| 2025-12-19 | Higgins Jack | -1,000 | - | - |
| 2025-12-19 | Higgins Jack | +1,000 | - | - |
| 2025-12-19 | Higgins Jack | -1,000 | - | - |
| 2025-12-19 | SIEGALL CLAY B | -200,000 | - | - |
| 2025-12-19 | SIEGALL CLAY B | +7,278 | $20.48 | $149,053 |
| 2025-12-18 | SIEGALL CLAY B | +46,511 | $21.5 | $999,987 |